HI Melanie,
I don't think you should worry too much about getting another week off from Taxol; you are still receiving Herceptin, right?
I'm wondering if your onc has second thoughts on the Taxol given your sensitivity to it, and is considering Taxotere which is a reformulated version of Taxol that is less likely to cause a reaction.
There is evidence that taxanes are beneficial in reducing recurrence in HER2+, ER/PR- BC, so be sure and do your research before your next visit with your onc.
Beyond that I don't feel qualified to advise you, but here's a link to some earlier posts on the subject of Taxol use in HER2+, ER/PR-:
http://her2support.org/vbulletin/sho...erceptin+taxol
Hope this helps.
<3 Lolly
__________________
Sept.'99 - Dx.Stage IIIB, IDC ER/PR-, HER2+++ by IHC, confirmed '04 by FISH. Left MRM, AC x's 4, Taxol x's 4, 33 Rads, finishing Tx May 2000. Jan.'01 - local/regional recurrence, Stage IV. Herceptin/Navelbine weekly till NED August 2001, then maintenance Herceptin. Right Mast. April 2002. Local/Regional recurrence April '04, Herceptin plus/minus chemo until May '07. Gemzar added from Feb.'07-April '07; Tykerb/Abraxane until August '07, back on Herceptin plus Taxotere and Xeloda Sept. '07. Stopped T/X Nov. '07, stopped Herceptin Dec. '07, started Avastin/Taxol/Carboplatin Dec. '07. Progression in chest skin, stopped TAC March '03, started radiation.
Herceptin has served as the "Backbone" of my treatment strategy for over 6 years, giving me great quality of life. In 2005, I was privileged to participate in the University of Washington/Seattle HER2 Vaccine Trial.
|